Press "esc" to clear
Go to Advanced Search
Showing results 2130 of 237
Ebolavirusresearcher-NicoleHoff.jpg

Article ID: 686837

40 Years After First Ebola Outbreak, Survivors Show Signs They Can Stave Off New Infection

University of California, Los Angeles (UCLA), Health Sciences

Survivors of the first known Ebola outbreak, which occurred in the Democratic Republic of the Congo in 1976, may be key to development of vaccines and therapeutic drugs to treat future outbreaks

Released:
14-Dec-2017 12:05 AM EST
Kawaoka-Sierra-Leone-8.jpg

Article ID: 685385

Unlocking the Secrets of Ebola

Pacific Northwest National Laboratory

Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease. The results come from one of the most in-depth studies ever of blood samples from patients with Ebola.

Released:
16-Nov-2017 4:05 PM EST
Ebolavial.JPG
  • Embargo expired:
    16-Nov-2017 12:00 PM EST

Article ID: 685218

In the Heart of Devastating Outbreak, Research Team Unlocks Secrets of Ebola

University of Wisconsin-Madison

In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin–Madison has identified signatures of Ebola virus disease that may aid in future treatment efforts.

Released:
14-Nov-2017 4:30 PM EST
nrhd-logo2017.png
  • Embargo expired:
    8-Nov-2017 8:55 AM EST

Article ID: 684299

Closing the Rural Health Gap: Media Update from RWJF and Partners on Rural Health Disparities

Newswise

Rural counties continue to rank lowest among counties across the U.S., in terms of health outcomes. A group of national organizations including the Robert Wood Johnson Foundation and the National 4-H Council are leading the way to close the rural health gap.

Released:
8-Nov-2017 8:55 AM EST

Law and Public Policy

Article ID: 682041

Researchers Identify Protein That Could Reduce Death, Improve Symptoms In Influenza and Other Infectious Diseases

University of Maryland School of Medicine

A new study by researchers has identified an innovative strategy for treating influenza, and perhaps other infectious diseases as well. Scientists showed that a small protein called retrocyclin-101 (RC-101) could potentially improve the symptoms and mortality associated with the flu and possibly other types of infectious illness as well.

Released:
29-Sep-2017 4:00 PM EDT

Article ID: 681870

Novel Vaccine for Ebola and other Hemorrhagic Fever Viruses

Thomas Jefferson University

A collaboration among research institutions, private industry, and the US Government will develop a tetravalent vaccine to protect against four viruses that can be fatal

Released:
27-Sep-2017 1:05 PM EDT
Harris-1.jpg

Article ID: 681595

Trusted Messages Key to Counter Community Concerns During Disease Outbreak

University of Louisville

Utilizing messages focused on images created by local artists and written information communicated through local dialects proved essential to counter misperceptions during the Ebola epidemic in Sierra Leone, according to a study conducted in part by Muriel J. Harris, Ph.D., associate professor, University of Louisville School of Public Health and Information Sciences, Department of Health Promotion and Behavior Sciences.

Released:
21-Sep-2017 3:40 PM EDT
Jean4.jpg

Article ID: 680041

DNA Detectives Crack the Case on Biothreat Look-Alikes

Los Alamos National Laboratory

Biological “detectives” are tracking down biothreats such as the bacteria that causes tularemia (“rabbit fever”), but they constantly face the challenge of avoiding false positives.

Released:
24-Aug-2017 2:05 PM EDT
Lai.jpg

Article ID: 679434

Einstein Researchers Awarded Three NIH Grants Totaling $12Million to Fight Virulent Viruses

Albert Einstein College of Medicine

The NIH has awarded Einstein researchers three grants totaling more than $12 million to protect against three deadly viruses—Ebola, Marburg and hantavirus. Research collaborations between Kartik Chandran, Ph.D., professor of microbiology & immunology and the Harold and Muriel Block Faculty Scholar in Virology, and Jonathan Lai, Ph.D., associate professor of biochemistry, have led to novel approaches for developing vaccines and treatments.

Released:
11-Aug-2017 11:05 AM EDT

Showing results 2130 of 237

Chat now!